State Offices of Rural Health Program Reauthorization Act of 2026
Summary
HB7956, the State Offices of Rural Health Program Reauthorization Act of 2026, would amend the Public Health Service Act to continue and extend federal support for state offices of rural health. The bill updates the authorization of appropriations for grants made under section 338J(i), setting funding levels of $12.5 million annually for fiscal years 2023 through 2027 and $13.5 million annually for fiscal years 2028 through 2032.
The measure is a reauthorization bill rather than a broad policy overhaul. Its primary purpose is to ensure that state offices of rural health can continue receiving federal grant support to coordinate and strengthen rural health systems, technical assistance, and related state-level rural health initiatives. By extending the authorization period and increasing the later funding level, the bill would maintain the statutory basis for ongoing federal appropriations to these offices.
Impact
The bill would amend section 338J(i) of the Public Health Service Act, changing the authorized funding amounts and extending the authorization window for the State Offices of Rural Health program. It would not itself appropriate money, but it would set the ceiling and timeline for future congressional appropriations supporting state rural health offices. The affected parties are state offices of rural health and, indirectly, rural providers, communities, and patients that rely on these offices for coordination, outreach, and access-related support.
Sentiment
Available context suggests the bill is likely to be viewed favorably as a routine reauthorization of an existing rural health program. There are no recorded committee transcripts or votes indicating controversy, and the bill’s sponsors and title signal support for continued federal assistance to rural health infrastructure. The overall sentiment appears pragmatic and supportive, focused on continuity of funding rather than ideological dispute.
Contention
No specific points of contention are reflected in the available record. If any debate were to arise, it would most likely concern the size of the authorized funding levels, the duration of the reauthorization, or broader questions about federal spending and the role of federal grants in supporting state health programs. However, the provided materials do not show opposition, amendments, or recorded objections.